162 related articles for article (PubMed ID: 22848688)
1. Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression.
Chung BH; Kim KW; Kim BM; Piao SG; Lim SW; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
PLoS One; 2012; 7(7):e42011. PubMed ID: 22848688
[TBL] [Abstract][Full Text] [Related]
2. The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.
Kim HY; Cho ML; Jhun JY; Byun JK; Kim EK; Yim YB; Chung BH; Yoon SK; Bae SH; Kim DG; Yang CW; Choi JY
Immunology; 2013 Feb; 138(2):124-33. PubMed ID: 23205589
[TBL] [Abstract][Full Text] [Related]
3. Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression.
Chung BH; Kim BM; Doh KC; Min JW; Cho ML; Kim KW; Yang CW
Transplantation; 2017 Jul; 101(7):1711-1719. PubMed ID: 28107277
[TBL] [Abstract][Full Text] [Related]
4. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
[TBL] [Abstract][Full Text] [Related]
5. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
Kim KW; Chung BH; Kim BM; Cho ML; Yang CW
Immunology; 2015 Jan; 144(1):68-78. PubMed ID: 24974886
[TBL] [Abstract][Full Text] [Related]
6. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
Doh KC; Kim BM; Kim KW; Chung BH; Yang CW
BMC Complement Altern Med; 2019 Mar; 19(1):54. PubMed ID: 30832648
[TBL] [Abstract][Full Text] [Related]
7. Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction.
Chung BH; Kim KW; Kim BM; Doh KC; Cho ML; Yang CW
PLoS One; 2015; 10(12):e0145258. PubMed ID: 26717145
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
[TBL] [Abstract][Full Text] [Related]
9. Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study.
Eteghadi A; Pak F; Ahmadpoor P; Jamali S; Karimi M; Yekaninejad MS; Kokhaei P; Nafar M; Amirzargar AA
Int Immunopharmacol; 2019 Feb; 67():319-325. PubMed ID: 30576916
[TBL] [Abstract][Full Text] [Related]
10. Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression.
Chung BH; Kim KW; Yu JH; Kim BM; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
Transpl Immunol; 2014 May; 30(4):159-67. PubMed ID: 24709525
[TBL] [Abstract][Full Text] [Related]
11. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
Lee SK; Park MJ; Jhun JY; Beak JA; Choi JW; Rye JY; Jang JW; Bae SH; Yoon SK; Choi HJ; You YK; Cho ML; Choi JY
Front Immunol; 2020; 11():581728. PubMed ID: 33488583
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
13. T helper subsets & regulatory T cells: rethinking the paradigm in the clinical context of solid organ transplantation.
Askar M
Int J Immunogenet; 2014 Jun; 41(3):185-94. PubMed ID: 24495112
[TBL] [Abstract][Full Text] [Related]
14. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
15. Significance of T helper 17 immunity in transplantation.
Abadja F; Sarraj B; Ansari MJ
Curr Opin Organ Transplant; 2012 Feb; 17(1):8-14. PubMed ID: 22186097
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Yago T; Nanke Y; Kawamoto M; Yamanaka H; Kotake S
Cytokine; 2012 Aug; 59(2):252-7. PubMed ID: 22579702
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
18. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
Mittal SK; Sharma RK; Gupta A; Naik S
Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
[TBL] [Abstract][Full Text] [Related]
20. Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis.
Brunialti MK; Santos MC; Rigato O; Machado FR; Silva E; Salomao R
PLoS One; 2012; 7(5):e37393. PubMed ID: 22693573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
